News
The glucagon-like peptide-1 (GLP-1) receptor agonist gained accelerated approval for patients with MASH and moderate to ...
The FDA has granted accelerated approval to semaglutide (Wegovy; Novo Nordisk) injection 2.4 mg for the treatment of adults with metabolic dysfunction–associated steatohepatitis (MASH) with moderate ...
With a new endorsement from the FDA, Novo Nordisk’s Wegovy has picked up its third indication and become the second drug ...
Wegovy is now approved by the FDA to treat metabolic-associated steatohepatitis in adults with moderate-to-advanced fibrosis ...
Enforcement of universal screenings would easily prevent sickness, expenses and death but enforcement isn’t easy.
16h
Health and Me on MSNGastroenterologist Warns: Cirrhosis Is Not Just About the Liver; It Can Impact Your Brain
When the liver is badly scarred by cirrhosis, the consequences are not just digestive. It can creep up and affect your brain ...
Gastroenterologist Dr Salhab warns that liver cirrhosis can lead to overt hepatic encephalopathy, impacting brain function and overall well-being.
Learn how to stop the progression of fatty liver disease with these common habit changes related to diet, exercise, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results